Condition: Acute Ischemic Stroke · Sponsor: Niguarda Hospital
The primary aim of Registrap study is to assess the safety and effectiveness of the EmboTrap®II Clot Retriever device (Neuravi) in patients with acute ischemic stroke from large vessel occlusion.
This description comes directly from the study's public registry record.
Edoardo Boccardi, MD · 00396444 · edoardo.bocccardi@ospedaleniguarda.it
Luca Valvassori, MD · 00396444 · luca.valvassori@gmail.com
Always discuss trial participation with your own doctor first.
| ASST GOM Niguarda | Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03601702